{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-001537","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.234203+00:00","generated_at":"2026-05-30T13:38:42.536492+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lexaria raises $5M via registered direct offering and private placement of warrants","bullets":["Gross proceeds of $5.0M from sale of 1,633,987 shares at $3.06/share plus 4,551,019 warrants exercisable at $3.06.","Warrants exercisable only after stockholder approval; expire 5 years from approval date.","Included cancellation of 2,917,032 outstanding warrants issued in April 2024.","Net proceeds to be used for working capital and general corporate purposes.","Placement agent H.C. Wainwright receives 7% cash fee and warrants for 57,190 shares at $3.825."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-001537","json":"https://secwatch.observer/filing/0001640334-24-001537.json","markdown":"https://secwatch.observer/filing/0001640334-24-001537.md","text":"https://secwatch.observer/filing/0001640334-24-001537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/0001640334-24-001537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001537/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:38:42.536492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}